All posts tagged "cabotegravir"
-
Multiple Paths to HIV Prevention: The Power of Choice
From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options.
-
FDA may approve long-acting injectable PrEP by January
The FDA has granted ViiV Healthcare priority review for cabotegravir, a new, injectable form of PrEP administered every two months.
-
PrEP injection every two months proves more effective than daily Truvada
GlaxoSmithKline stopped clinical trials of the PrEP drug early due to its efficacy at preventing new HIV transmissions
-
Bimonthly injections as effective as pills at treating HIV
A bimonthly injection may eventually replace daily oral medication in the treatment of HIV
